Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.22B
Enterprise Value2.19B
P/E Ratio-54.04
PEG Ratio0.38
Price/Sales Ratio4.73
Price/Book Ratio1.42
Enterprise/Revenue4.64
Enterprise/EBITDA-93.09

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.1
Operating Margin-0.12
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.03

Income Statement

Revenue342.25M
Revenue/Share3.79
Gross Profit219.22M
EBITDA-19.77M
Net Income-47.02M
Diluted EPS-0.5

Balance Sheet

Total Cash300.24M
Total Cash/Share3.21
Total Debt2.73M
Total Debt/Equity0
Current Ratio9.43
Book Value Per Share12.37

Price History

52-Week Change-45.2
52-Week High38.96
52-Week Low15.7
Moving Average 50 Days19.07
Moving Average 200 Days23.9

Statistics

Average Volume1.73M
Shares Outstanding93.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.56
Payout Ratio-0.52
Last Split FactorN/A
Last Split DateN/A
AD